Sukanya Manosuthi Selected Research

efavirenz (Sustiva)

1/2014	CYP2B6 18492T->C polymorphism compromises efavirenz concentration in coinfected HIV and tuberculosis patients carrying CYP2B6 haplotype 1/1.
2/2013	Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sukanya Manosuthi Research Topics

Disease

2	Body Weight (Weight, Body) 01/2014 - 02/2013
2	Tuberculosis (Tuberculoses) 01/2014 - 02/2013
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 02/2013

Drug/Important Bio-Agent (IBA)

2	efavirenz (Sustiva)FDA Link 01/2014 - 02/2013
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2014 - 02/2013
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2014